PLAT and stroke disorder: Recent studies have indicated that neural-stem-cell (NSC)-derived EVs administered both within and outside the t-PA therapeutic window result in a significant reduction in infarct volume, exhibiting better therapeutic effects in stroke compared to MSC-EVs [38].